OrganoClick Balance Sheet Health

Financial Health criteria checks 1/6

OrganoClick has a total shareholder equity of SEK46.1M and total debt of SEK35.3M, which brings its debt-to-equity ratio to 76.7%. Its total assets and total liabilities are SEK146.6M and SEK100.5M respectively.

Key information

76.7%

Debt to equity ratio

SEK 35.32m

Debt

Interest coverage ration/a
CashSEK 4.34m
EquitySEK 46.06m
Total liabilitiesSEK 100.51m
Total assetsSEK 146.57m

Recent financial health updates

Recent updates

A Piece Of The Puzzle Missing From OrganoClick AB (publ)'s (STO:ORGC) 26% Share Price Climb

Jun 19
A Piece Of The Puzzle Missing From OrganoClick AB (publ)'s (STO:ORGC) 26% Share Price Climb

Shareholders May Find It Hard To Justify Increasing OrganoClick AB (publ)'s (STO:ORGC) CEO Compensation For Now

May 09
Shareholders May Find It Hard To Justify Increasing OrganoClick AB (publ)'s (STO:ORGC) CEO Compensation For Now

Earnings Release: Here's Why Analysts Cut Their OrganoClick AB (publ) (STO:ORGC) Price Target To kr3.00

May 03
Earnings Release: Here's Why Analysts Cut Their OrganoClick AB (publ) (STO:ORGC) Price Target To kr3.00

Sentiment Still Eluding OrganoClick AB (publ) (STO:ORGC)

Mar 25
Sentiment Still Eluding OrganoClick AB (publ) (STO:ORGC)

Earnings Update: OrganoClick AB (publ) (STO:ORGC) Just Reported And Analysts Are Trimming Their Forecasts

Feb 18
Earnings Update: OrganoClick AB (publ) (STO:ORGC) Just Reported And Analysts Are Trimming Their Forecasts

OrganoClick (STO:ORGC) Seems To Use Debt Quite Sensibly

Jan 09
OrganoClick (STO:ORGC) Seems To Use Debt Quite Sensibly

Is OrganoClick AB (publ) (STO:ORGC) Potentially Undervalued?

May 11
Is OrganoClick AB (publ) (STO:ORGC) Potentially Undervalued?

There's No Escaping OrganoClick AB (publ)'s (STO:ORGC) Muted Revenues Despite A 33% Share Price Rise

Apr 18
There's No Escaping OrganoClick AB (publ)'s (STO:ORGC) Muted Revenues Despite A 33% Share Price Rise

Here's Why OrganoClick (STO:ORGC) Can Afford Some Debt

Jan 25
Here's Why OrganoClick (STO:ORGC) Can Afford Some Debt

Does OrganoClick (STO:ORGC) Have A Healthy Balance Sheet?

Sep 21
Does OrganoClick (STO:ORGC) Have A Healthy Balance Sheet?

OrganoClick AB (publ) (STO:ORGC) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 21
OrganoClick AB (publ) (STO:ORGC) Just Reported Earnings, And Analysts Cut Their Target Price

Health Check: How Prudently Does OrganoClick (STO:ORGC) Use Debt?

Feb 20
Health Check: How Prudently Does OrganoClick (STO:ORGC) Use Debt?

Is OrganoClick (STO:ORGC) Weighed On By Its Debt Load?

Apr 20
Is OrganoClick (STO:ORGC) Weighed On By Its Debt Load?

Loss-Making OrganoClick AB (publ) (STO:ORGC) Expected To Breakeven In The Medium-Term

Mar 23
Loss-Making OrganoClick AB (publ) (STO:ORGC) Expected To Breakeven In The Medium-Term

Should You Take Comfort From Insider Transactions At OrganoClick AB (publ) (STO:ORGC)?

Feb 12
Should You Take Comfort From Insider Transactions At OrganoClick AB (publ) (STO:ORGC)?

What Percentage Of OrganoClick AB (publ) (STO:ORGC) Shares Do Insiders Own?

Jan 05
What Percentage Of OrganoClick AB (publ) (STO:ORGC) Shares Do Insiders Own?

Analysts Expect Breakeven For OrganoClick AB (publ) (STO:ORGC) Before Long

Dec 18
Analysts Expect Breakeven For OrganoClick AB (publ) (STO:ORGC) Before Long

Financial Position Analysis

Short Term Liabilities: ORGC's short term assets (SEK68.4M) do not cover its short term liabilities (SEK93.4M).

Long Term Liabilities: ORGC's short term assets (SEK68.4M) exceed its long term liabilities (SEK7.2M).


Debt to Equity History and Analysis

Debt Level: ORGC's net debt to equity ratio (67.3%) is considered high.

Reducing Debt: ORGC's debt to equity ratio has increased from 51.1% to 76.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ORGC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if ORGC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies